Skip to main content

Figure 4.

Figure 4

Patient survival according to the expression of S100A2 in patients with p53‐positive or p53‐negative tumors. (a) S100A2 positivity was not associated with prognosis of patients with p53‐positive tumors (P = 0.6517). (b) S100A2 positivity was significantly associated with favorable outcome in patients with p53‐negative tumors (P = 0.0448).